Historical Price Chart

Akebia Therapeutics, Inc. (AKBA)

Loading chart data...

Is Akebia Therapeutics, Inc. (AKBA) Stock a Buy in 2025?

YES

BUY

Score: 72/100

Yes, AKBA stock appears to be a good buy in 2025 based on our comprehensive analysis.

Growth Drivers

Healthcare sector momentum

Valuation Considerations

Analyst price targets suggest 128.0% upside potential
Small-cap with higher growth potential and volatility

Risk Factors

High debt-to-equity ratio of 670.33
Healthcare sector cyclicality
Small-cap liquidity and volatility risks

Analyst Consensus

Buy Ratings:8

Hold Ratings:1

Sell Ratings:1

Avg. Price Target:$7.50

Upside Potential:128.0%

Investment Summary

AKBA presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 128.0% upside potential.

Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.

Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 670.33, and consider their own risk tolerance and investment timeline.

Final Recommendation

BUY

Recommendation Score

Overall Score:72/100

Buy

2030 Price Prediction

Predicted Price:$10.04

Potential Return:+205.2%

Key Factors

Significantly declining revenue
Very strong analyst buy consensus
Very significant upside potential
Exceptional long-term growth potential to 2030
Extremely high debt levels
Debt-to-Market-Cap Ratio: 22.5% (Healthy)

Investment Decision

Based on our comprehensive analysis of AKBA's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.

akba Stock Price Prediction 2030

Predicted 2030 Price

$10.04

+205.2%from current price

Based on revenue growth analysis and market trends, akba stock is projected to reach $10.04 by 2030, representing a 205.2% increase from the current price of $3.29.

Current Price

$3.29

Revenue Growth

43.1%

Analyst Target

$7.50

View Full Prediction Analysis

Get detailed analyst targets, key factors, and comprehensive forecast analysis

How to Invest in akba Stock?

1. Research Fundamentals

Analyze financial statements and market position

2. Technical Analysis

Review price charts and technical indicators

3. Risk Assessment

Evaluate market and company-specific risks

4. Investment Decision

Make buy/hold/sell decision with price targets

Company Profile